Search Orphan Drug Designations and Approvals
-
Generic Name: | cyclocreatine phosphate |
---|---|
Date Designated: | 01/17/2018 |
Orphan Designation: | Prevention of ischemic injury to enhance cardiac graft recovery and survival in heart transplantation. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Nour Heart Therapeutics, LLC 121 Locust Street, SW Vienna, Virginia 22180 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-